Table 1.

Relative repopulating abilities of SCL-heterozygous and SCL-deleted bone marrow


Experiment (donor RUs/competitor RUs, × 105)

SCL-heterozygous

SCL-deleted

Fold reduction
1 (20/5)    
Myeloid lineage   67 (10)   11 (0.62)   16.5  
B-cell lineage   85 (28)   34 (2.6)   10.8  
T-cell lineage   90 (45)   29 (2.0)   22.5  
2 (20/5)    
Myeloid lineage   69 (11)   22 (1.4)   7.9  
B-cell lineage   82 (22)   53 (5.6)   4.0  
T-cell lineage   ND   ND   ND  
3 (20/2)    
Myeloid lineage   87 (13)   34 (1.0)   13  
B-cell lineage   86 (12)   56 (2.5)   4.8  
T-cell lineage
 
87 (13)
 
41 (1.4)
 
9.3
 

Experiment (donor RUs/competitor RUs, × 105)

SCL-heterozygous

SCL-deleted

Fold reduction
1 (20/5)    
Myeloid lineage   67 (10)   11 (0.62)   16.5  
B-cell lineage   85 (28)   34 (2.6)   10.8  
T-cell lineage   90 (45)   29 (2.0)   22.5  
2 (20/5)    
Myeloid lineage   69 (11)   22 (1.4)   7.9  
B-cell lineage   82 (22)   53 (5.6)   4.0  
T-cell lineage   ND   ND   ND  
3 (20/2)    
Myeloid lineage   87 (13)   34 (1.0)   13  
B-cell lineage   86 (12)   56 (2.5)   4.8  
T-cell lineage
 
87 (13)
 
41 (1.4)
 
9.3
 

Repopulating units (RUs) are defined as the repopulating ability of 1 × 105 fresh marrow cells from the SCL-wild-type competitor. The mean percentage of donor-derived cells for each lineage at 16 weeks are given, each calculated from a group of 3 to 5 recipients. The method of calculation for the RUs given in parentheses is described in “Materials and methods.” The fold reduction was calculated by dividing the RUs of SCL-heterozygous donor cells by the RUs of SCL-deleted donor cells.

ND indicates not done.

Close Modal

or Create an Account

Close Modal
Close Modal